Stay updated with breaking news from Nasdaq Pdex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report published on Saturday morning. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Trading Down 1.8 % Shares of Pro-Dex stock opened at $15.95 on Friday. The company’s fifty day simple moving average is $16.41 and its […]
Pro-Dex (NASDAQ:PDEX – Get Rating) and Sensus Healthcare (NASDAQ:SRTS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability. Institutional & Insider Ownership 13.5% of Pro-Dex shares are held […]
Equities researchers at StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a report issued on Friday. The firm set a “buy” rating on the medical instruments supplier’s stock. Pro-Dex Stock Down 2.3 % Shares of PDEX opened at $16.30 on Friday. Pro-Dex has a one year low of $12.40 and a […]
Pro-Dex, Inc. (NASDAQ:PDEX – Get Rating) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 11,300 shares, a decline of 20.4% from the March 15th total of 14,200 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average trading volume […]
Pro-Dex (NASDAQ:PDEX – Get Rating) and Cytosorbents (NASDAQ:CTSO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings. Risk and Volatility Pro-Dex has a beta of 0.99, meaning that […]